Suprecur nasal spray

Pays: Nouvelle-Zélande

Langue: anglais

Source: Medsafe (Medicines Safety Authority)

Achète-le

Ingrédients actifs:

Buserelin acetate 1.575 mg/g equivalent to 1.50 mg/mL Buserelin

Disponible depuis:

sanofi-aventis new zealand limited

DCI (Dénomination commune internationale):

Buserelin acetate 1.575 mg/g (= 1.50 mg/mL Buserelin)

Dosage:

150 mcg/dose

forme pharmaceutique:

Nasal spray solution

Composition:

Active: Buserelin acetate 1.575 mg/g equivalent to 1.50 mg/mL Buserelin Excipient: Benzalkonium chloride Citric acid monohydrate Sodium chloride Sodium citrate dihydrate Water for injection

Unités en paquet:

Bottle, glass, 2 x 100 spray doses, 200 dose units

classe:

Prescription

Type d'ordonnance:

Prescription

Fabriqué par:

Sanofi-Aventis Deutschland GmbH

Descriptif du produit:

Package - Contents - Shelf Life: Bottle, glass, 2 x 100 spray doses - 200 dose units - 36 months from date of manufacture stored at or below 25°C

Date de l'autorisation:

1993-03-26

Afficher l'historique des documents